Skip to main content
Clinical Trials/IRCT20160307026950N16
IRCT20160307026950N16
Recruiting
Phase 3

Comparative evaluation of midazolam effects before and after seizure occurrence on post ECT complications in teenagers

Esfahan University of Medical Sciences0 sites69 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
electroconvulsive therapy complications.
Sponsor
Esfahan University of Medical Sciences
Enrollment
69
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 13 to 18 years of age
  • Having indications for ECT
  • Written consent from parents
  • NPO regimen

Exclusion Criteria

  • Patients who do not have a stable Hemodynamic status
  • Patients with major diseases like asthma, drug allergy, neuromuscular diseases ,epilepsy, hypertension and cardiovascular diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials